Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Ingelsson

Showing results (11-20 of 217) with videos related to

Pageof 22
Sort By:
Frontiers in Molecular Biosciences|February 16, 2023
Studies on alpha-synuclein and islet amyloid polypeptide interactionYe Wang, Joakim Bergström, Martin Ingelsson, et al.
STAR Protocols|November 7, 2025
Protocol for immunodetection of α-synuclein pathology in paraffin-embedded liver tissues from murine models of Parkinson's diseaseMartin Hallbeck, Maria Ntzouni, Martin Ingelsson, et al.
Brain and Behavior|June 2, 2022
Modeling Parkinson's disease-related symptoms in alpha-synuclein overexpressing miceAgata Aniszewska, Joakim Bergström, Martin Ingelsson, et al.
Journal of Alzheimer'S Disease : JAD|October 31, 2022
Mixed Pathologies in a Subject with a Novel PSEN1 G206R MutationSylwia Libard, Vilmantas Giedraitis, Lena Kilander, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|December 15, 2024
A brain-penetrant bispecific antibody lowers oligomeric alpha-synuclein and activates microglia in a mouse model of alpha-synuclein pathologyDag Sehlin, Sahar Roshanbin, Olof Zachrisson, et al.
Acta Neuropathologica Communications|February 26, 2024
Astrocytic accumulation of tau fibrils isolated from Alzheimer's disease brains induces inflammation, cell-to-cell propagation and neuronal impairmentKhalid Eltom, Tobias Mothes, Sylwia Libard, et al.
Lakartidningen|January 18, 2006
[Conformationally altered proteins cause neurodegenerative diseases]Martin Ingelsson, Lars Nilsson, Hans Basun, et al.
Neuropharmacology|August 12, 2017
Intact blood-brain barrier transport of small molecular drugs in animal models of amyloid beta and alpha-synuclein pathologySofia Gustafsson, Veronica Lindström, Martin Ingelsson, et al.
Plos One|January 10, 2020
Torque teno virus viral load is related to age, CMV infection and HLA type but not to Alzheimer's diseaseGabriel Westman, Catherine Schoofs, Martin Ingelsson, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
Clinical ManifestationsJuan-Camilo Vargas-González, Martin Ingelsson, David F Tang-Wai, et al.
Pageof 22

Showing results (11-20 of 217) with videos related to

Sort By:
Pageof 22
Frontiers in Molecular Biosciences|February 16, 2023
Studies on alpha-synuclein and islet amyloid polypeptide interactionYe Wang, Joakim Bergström, Martin Ingelsson, et al.
STAR Protocols|November 7, 2025
Protocol for immunodetection of α-synuclein pathology in paraffin-embedded liver tissues from murine models of Parkinson's diseaseMartin Hallbeck, Maria Ntzouni, Martin Ingelsson, et al.
Brain and Behavior|June 2, 2022
Modeling Parkinson's disease-related symptoms in alpha-synuclein overexpressing miceAgata Aniszewska, Joakim Bergström, Martin Ingelsson, et al.
Journal of Alzheimer'S Disease : JAD|October 31, 2022
Mixed Pathologies in a Subject with a Novel PSEN1 G206R MutationSylwia Libard, Vilmantas Giedraitis, Lena Kilander, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|December 15, 2024
A brain-penetrant bispecific antibody lowers oligomeric alpha-synuclein and activates microglia in a mouse model of alpha-synuclein pathologyDag Sehlin, Sahar Roshanbin, Olof Zachrisson, et al.
Acta Neuropathologica Communications|February 26, 2024
Astrocytic accumulation of tau fibrils isolated from Alzheimer's disease brains induces inflammation, cell-to-cell propagation and neuronal impairmentKhalid Eltom, Tobias Mothes, Sylwia Libard, et al.
Lakartidningen|January 18, 2006
[Conformationally altered proteins cause neurodegenerative diseases]Martin Ingelsson, Lars Nilsson, Hans Basun, et al.
Neuropharmacology|August 12, 2017
Intact blood-brain barrier transport of small molecular drugs in animal models of amyloid beta and alpha-synuclein pathologySofia Gustafsson, Veronica Lindström, Martin Ingelsson, et al.
Plos One|January 10, 2020
Torque teno virus viral load is related to age, CMV infection and HLA type but not to Alzheimer's diseaseGabriel Westman, Catherine Schoofs, Martin Ingelsson, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
Clinical ManifestationsJuan-Camilo Vargas-González, Martin Ingelsson, David F Tang-Wai, et al.
Pageof 22